# glycopyrrolate

NDC: 71839-124
Generic name: glycopyrrolate
Labeler / Manufacturer: BE Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20220310

FDA application: ANDA211705

## Active ingredients

- GLYCOPYRROLATE: .4 mg/2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71839-124"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71839-124
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d9df3900-a8c2-438b-8971-ba11ff91f90b